Why Bristol-Myers Squibb Co.'s Stock Could Sink
Bristol-Myers Squibb's share price has been going through the roof due to the company's emergence as a leader in the field of immuno-oncology. This big pharma's high-flying days might be numbered, however. Here's why.
Better Buy: Gilead Sciences Inc. or Celgene Corporation?
Celgene and Gilead have been great stocks to own over the past few years. Which one is a better buy at today's prices?